Table 1.
Characteristics of Clinical Samples Used in the Study
| Sample | Age (yr) | Sex | Ct Value for SARS-CoV-2 E Gene | Ct Value for SARS-CoV-2 RdRp Gene | Category |
|---|---|---|---|---|---|
| 1S | 32 | M | 18.5 | 15.46 | 2 |
| 2S | 41 | F | 17.48 | 15.36 | 6 |
| 3S | 44 | M | 13.46 | 12.01 | 6 |
| 4S | 39 | F | 13.22 | 12.67 | 2 |
| 5S | 36 | M | 12.08 | 14.55 | 6 |
| 6S | 42 | F | 12.28 | 9.4 | 4 |
| 7S | 37 | M | 16.26 | 15.42 | 4 |
| 8S | 28 | F | 17.15 | 15.62 | 4 |
| 9AS | 32 | M | 10.45 | 10.8 | 5a |
| 10AS | 31 | F | 12.32 | 12.4 | 5a |
| 11AS | 26 | M | 15.33 | 12.52 | 5a |
| 12AS | 35 | F | 10.59 | 12.4 | 5a |
| 13AS | 38 | M | 15.77 | 12.89 | 5a |
| 14AS | 29 | F | 18.07 | 10.72 | 5a |
| 15AS | 33 | M | 15.64 | 13.81 | 5a |
| 1C | 33 | M | Nd | Nd | Control |
| 2C | 39 | F | Nd | Nd | Control |
| 3C | 45 | M | Nd | Nd | Control |
| 4C | 39 | F | Nd | Nd | Control |
| 5C | 34 | M | Nd | Nd | Control |
| 6C | 44 | F | Nd | Nd | Control |
| 7C | 35 | M | Nd | Nd | Control |
| 8C | 30 | F | Nd | Nd | Control |
| 9C | 30 | M | Nd | Nd | Control |
| 10C | 32 | F | Nd | Nd | Control |
| 11C | 29 | M | Nd | Nd | Control |
| 12C | 33 | F | Nd | Nd | Control |
| 13C | 40 | M | Nd | Nd | Control |
| 14C | 32 | F | Nd | Nd | Control |
| 15C | 30 | M | Nd | Nd | Control |
Definition of abbreviations: Ct = cycle threshold; Nd = not detected; RdRp = RNA-dependent RNA polymerase; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.